Get the Stockscreener App
2.13
11.20%
-0.28
Tenaya Therapeutics Inc stock is traded at $2.13, with a volume of 6.70M.
It is down -11.20% in the last 24 hours and up +20.90% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
See More
Previous Close:
$2.41
Open:
$2.38
24h Volume:
6.70M
Relative Volume:
5.96
Market Cap:
$172.57M
Revenue:
-
Net Income/Loss:
$-124.08M
P/E Ratio:
-0.9552
EPS:
-2.23
Net Cash Flow:
$-103.31M
1W Performance:
+9.18%
1M Performance:
+20.90%
6M Performance:
-54.27%
1Y Performance:
-4.89%
1-Day Range:
$2.00
$2.435
1-Week Range:
$1.85
$2.75
52-Week Range:
$1.61
$7.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
abrdn plc Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - MarketBeat
BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation - Yahoo Finance
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Piper Sandler raises confidence in Tenaya Therapeutics stock ahead of December data, reiterates Overweight rating - Investing.com Australia
Tenaya shares retain stock target, buy rating on safety milestone - Investing.com
Tenaya shares hold buy rating, positive outlook on trial progress - Investing.com
Tenaya Therapeutics' (TNYA) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat
Leerink sees Tenaya's trial update as positive, maintains price target By Investing.com - Investing.com UK
Tenaya stock undervalued despite strong Ph1 safety update, says Canaccord - Investing.com
Tenaya (TNYA) Experiences Notable Stock Increase Following Key Update - Stocks Telegraph
Tenaya advances gene therapy trial for heart condition - Investing.com
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM - GlobeNewswire
SVP, Accounting and Fin. Ops. Saito Chihiro sold 2,363 shares of Tenaya Therapeutics Inc [TNYA] - Knox Daily
Tenaya Therapeutics stock hits 52-week low at $1.63 By Investing.com - Investing.com Canada
Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News
A Closer Look at Tenaya Therapeutics Inc (TNYA) Stock Gains - The InvestChronicle
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of “Buy” by Brokerages - Defense World
Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart
Charting the Course: Tenaya Therapeutics Inc’s TNYA Stock Prospects - The InvestChronicle
Tenaya Therapeutics Inc (TNYA) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Daily Progress: Tenaya Therapeutics Inc (TNYA) Drop -3.11, Closing at 1.87 - The Dwinnex
Tenaya Therapeutics Inc [TNYA] Insider Activity: An Update for Investors - Knox Daily
Canaccord keeps buy rating, price target on Tenaya shares - Investing.com
Tenaya Therapeutics' SWOT analysis: gene therapy stock poised for pivotal catalysts By Investing.com - Investing.com South Africa
Tenaya Therapeutics' SWOT analysis: gene therapy stock poised for pivotal catalysts - Investing.com India
Myocardial Infarction Global Market Report 2024 Size and Forecast - WhaTech
A closer look at Tenaya Therapeutics Inc (TNYA)’s stock price trends - US Post News
Owning 43% shares,institutional owners seem interested in Tenaya Therapeutics, Inc. (NASDAQ:TNYA), - Yahoo Finance
Rocket Pharmaceuticals Maxes Out Recruitment in Pivotal Trial for Danon Disease Gene Therapy RP-A501 - CGTLive™
Recent Insider Activity Could Benefit Tenaya Therapeutics Inc (TNYA) - Knox Daily
Tenon Medical Inc (TNON) expanding its growth trajectory ahead - SETE News
Tenet Healthcare Corp. (THC) Stock: A Year of Market Fluctuations - The InvestChronicle
Daily Market Movement: Tenon Medical Inc (TNON) Sees a -18.94 Decrease, Closing at 6.25 - The Dwinnex
Choreo LLC Invests $335,000 in Tenet Healthcare Co. (NYSE:THC) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com - Defense World
TELA’s latest rating updates from top analysts. - Knox Daily
Tenet Healthcare (NYSE:THC) Stock Price Down 2.3% - MarketBeat
Nothing is Better Than Tenaya Therapeutics Inc (TNYA) stock at the moment - SETE News
Closing Bell Recap: TELA Bio Inc (TELA) Ends at 2.49, Reflecting a -6.04 Downturn - The Dwinnex
Tenaya Therapeutics reshuffles board, introduces new equity plan By Investing.com - Investing.com Australia
Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - AccessWire
Financial Health Report: Tenaya Therapeutics Inc (TNYA)’s Ratios Tell a Tale - The Dwinnex
Teekay Tankers Ltd. (NYSE:TNK) Shares Sold by Daiwa Securities Group Inc. - Defense World
Los Angeles Capital Management LLC Acquires Shares of 27,772 TELA Bio, Inc. (NASDAQ:TELA) - Defense World
American Century Companies Inc. Buys 93,788 Shares of Teekay Tankers Ltd. (NYSE:TNK) - Defense World
Tenaya Therapeutics reshuffles board, introduces new equity plan - Investing.com
Tenet Healthcare (THC) Rises Higher Than Market: Key Facts - Yahoo Finance
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tenaya Therapeutics Inc Stock (TNYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Aug 16 '24 |
Sale |
2.89 |
7,428 |
21,500 |
107,106 |
| Ali Faraz | Chief Executive Officer |
Aug 16 '24 |
Sale |
2.89 |
9,748 |
28,216 |
188,331 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):